Indeed, Lee et al. previously observed in vitro that the AR pathway activation in LNCaP cells was reduced following enzalutamide treatment or exposure to low androgen levels, while the Wnt/β-linked protein-responsive transcriptional activity was enhanced, leading to more robust tumor cell growth [169]. Here, AR is linked to neoplasm.